Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sirnaomics Ltd. ( (HK:2257) ) just unveiled an announcement.
Sirnaomics Ltd. announced the successful passing of all resolutions at its Annual General Meeting held on June 20, 2025. Key decisions included the re-election of directors, re-appointment of auditors, and granting mandates for share issuance and buybacks, reflecting strong shareholder support and strategic positioning for future growth.
More about Sirnaomics Ltd.
Sirnaomics Ltd. operates in the biotechnology industry, focusing on the development of RNAi therapeutics for the treatment of cancer and fibrotic diseases. The company is known for its innovative approach in leveraging RNA interference technology to address unmet medical needs.
Average Trading Volume: 236,978
Technical Sentiment Signal: Hold
Current Market Cap: HK$429.1M
Find detailed analytics on 2257 stock on TipRanks’ Stock Analysis page.